Evidence map›Paper›PMID 33445812›Full record

ArticleNanomaterials (Basel, Switzerland)2021

Design of PEGylated Three Ligands Silica Nanoparticles for Multi-Receptor Targeting.

Manon Maurel, Titouan Montheil, Julie Martin, Line Chaar, Veronica Guzman-Gonzalez, Morgane Couvet, Thibault Jacquet, Tao Jia, Beatrice Eymin, Karine Parra and 7 more

Abstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Silylated biomolecules: Versatile components for bioinks.Frontiers in bioengineering and biotechnology · 2022
    Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Manon MaurelInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.ORCID 0000-0001-8462-3034
Titouan MontheilInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.
Julie MartinInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.ORCID 0000-0003-0905-8332
Line ChaarInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.
Veronica Guzman-GonzalezInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.ORCID 0000-0001-9385-5857
Morgane CouvetInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.
Thibault JacquetInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.
Tao JiaInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.
Beatrice EyminInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.
Karine ParraInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.
Pascal DumyInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.
Jean MartinezInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.
Florence RuggieroInstitut de Génomique Fonctionnelle de Lyon, ENS de Lyon, UMR CNRS 5242, Université Lyon 1, CEDEX 07, 69364 Lyon, France.
Elisabeth VaganayInstitut de Génomique Fonctionnelle de Lyon, ENS de Lyon, UMR CNRS 5242, Université Lyon 1, CEDEX 07, 69364 Lyon, France.
Ahmad MehdiICGM, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.ORCID 0000-0002-7830-2012
Jean-Luc CollInstitute for Advanced Biosciences, INSERM-UGA U1209, CNRS UMR 5309, 38700 La Tronche, France.ORCID 0000-0002-2453-3552
Gilles SubraInstitute of Biomolecules Max Mousseron, Université de Montpellier, ENSCM, CNRS, 34095 Montpellier, France.ORCID 0000-0003-4857-4049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The synthesis of silica nanoparticles (SiNPs) decorated on their surface with a range of various elements (e.g., ligands, drugs, fluorophores, vectors, etc.) in a controlled ratio remains a big challenge. We have previously developed an efficient strategy to obtain in one-step, well-defined multifunctional fluorescent SiNPs displaying fluorophores and two peptides ligands as targeting elements, allowing selective detection of cancer cells. In this paper, we demonstrate that additional level of controlled multifunctionality can be achieved, getting even closer to the original concept of "magic bullet", using solely sol-gel chemistry to achieve conjugation of PEG chains for stealth, along with three different ligands. In addition, we have answered the recurrent question of the surface ungrafting by investigating the stability of different siloxane linkages with the ERETIC Method (Electronic Reference to Access

Indexed as

cancer targetingfluorophoresilica nanoparticlessilylated peptidessol–gelsurface functionalization

Identifiers

PMID33445812
PMCPMC7828255

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.